TX-COGNITIVE-SPACE
8.12.2021 04:42:05 CET | Business Wire | Press release
Cognitive Space announced the highlights of a very successful year in its mission to dramatically improve the way we monitor the Earth for economic, environmental, and national security understanding. The company helps organizations fly their satellites with new tools for New Space - providing satellite operators and space infrastructure companies with sophisticated SaaS services for optimizing revenue and performance yield, forecasting future capacity, and orchestrating collection management as satellite constellations grow and scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207006237/en/
“The New Space economy is attracting massive investment and is growing exponentially. Space will be filled with thousands of new commercial satellites,” said Scott Herman, CEO of Cognitive Space. “But building out the required ground architecture is a major hurdle for New Space companies and usually represents a significant monetary investment, a multi-year time commitment, and major execution risk as they build their business. Cognitive Space provides a blueprint and an operational capability that de-risks and accelerates their buildout schedule, controls costs, and then optimizes their ongoing operations to power their business vision.”
2021 Highlights for Cognitive Space:
$5.5M in Investment Capital raised – Cognitive Space started the year with a $1.5M “pre-seed” raise, followed in November with the closing of a $4M Series Seed led by Grit Ventures of Menlo Park. Additional investors include Argon Ventures, Techstars, UltraTech Capital Partners, Cultivation Capital, Glasswing Ventures, Gutbrain Ventures, PBJ Capital, SpaceFund, and Deep Ventures. Outside counsel for the transaction were Covington and Burling LLP. As a result of this 2021 fundraising effort, Cognitive Space enters 2022 with $5.5M in funds ready to apply towards commercial product development and company growth.
“Billions of investment dollars are flowing into the New Space economy. There is an unmet imperative for cost-effective, scalable, and business-savvy constellation operations,” commented Jennifer Gill Roberts, Managing Partner at Grit Ventures. “We believe Cognitive Space's AI-driven approach to maximizing constellation revenue and performance yield gives their customers a significant competitive advantage in this emerging market for Space-based services.”
New and expanded US Government contracts – Cognitive Space continued its work with several US Government agencies, including the US Space Force, the Air Force Research Lab (AFRL), the National Geospatial Intelligence Agency (NGA), and other members of the national security community. In these engagements Cognitive Space focused on concept development and rapid prototyping for topics such as orchestrated collection management, hybrid space architecture, and global monitoring. Of particular note, Cognitive Space was selected as a winner of the Space Force Pitch Day competition, resulting in a $1.7M contract for exploring new approaches to satellite operations using Artificial Intelligence.
Cognitive Space also supported several US Government exercises, including RIMPAC, Northern Edge, and Joint Warrior. The company orchestrated collection opportunities across multiple commercial and government suppliers of satellite remote sensing. Cognitive Space provided the US Government with insight into the emerging wave of commercial remote sensing capabilities, helping them understand the impact of these capabilities on future operations, tradecraft, tools, and procurement methods.
Commercial Sales Traction – This summer, Cognitive Space introduced its SaaS-based platform for autonomous and dynamic satellite operations to a growing set of commercial satellite operators and space infrastructure companies. The platform revolutionizes satellite operations with the power of artificial intelligence for mission management, collections planning, and communications link coordination. The suite is available in versions tailored for startups, growth, and enterprise-class customers in the New Space domain.
Strong Revenue growth – Cognitive Space continues to dramatically increase its year-over-year revenue with new contracts, solid bookings, and a dense opportunity pipeline going into 2022.
Accelerator Wins – Cognitive Space was competitively selected for several startup accelerators, including the Amazon Web Services (AWS) Seraphim Space Accelerator and the NGA Startup Accelerator. As one of 10 companies chosen by AWS out of a field of approximately 200 startups, Cognitive Space received $100,000 in cloud infrastructure credits, AWS Cloud training and support, mentorship, and additional business development resources including opportunities to speak with space-savvy venture investors. With the NGA Accelerator, Cognitive Space has been working with government analysts on a pilot project exploring the role of future commercial satellite capabilities for facility monitoring and pattern-of-life analytics in real-world scenarios.
Building the best team in AI-driven Satellite Operations – Cognitive Space continues to recruit aggressively for an expanding team of AI/ML scientists and mathematicians, satellite and aerospace engineers, full-stack and frontend/backend developers, system architects, and Cloud DevOps engineers. In 2021, the company also made strategic additions to the executive team by recruiting senior industry veterans Scott Herman (as CEO) and Hanna Steplewska (as VP, Business Development & Operations). Scott and Hanna bring deep experience in Space Operations, Satellite Remote Sensing, Geospatial Analytics, and National Security and a comprehensive understanding of the New Space ecosystem.
About Cognitive Space
More information about Cognitive Space can be found at http://www.cognitivespace.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207006237/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom